Type 2 diabetes complications;Complications du diabète de type 2

Presse Medicale

Volumn 42, Issue 5, 2013, Pages 839-848

  Schlienger, Jean Louis ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROGENESIS; BLOOD PRESSURE REGULATION; BONE DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; GERIATRIC PATIENT; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FAILURE; MALIGNANT NEOPLASTIC DISEASE; METABOLIC REGULATION; MICROALBUMINURIA; MICROANGIOPATHY; MOOD DISORDER; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; SCREENING TEST; SHORT SURVEY; SLEEP DISORDERED BREATHING;

BONE DISEASES; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; CYTOKINES; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC FOOT; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; DISEASE SUSCEPTIBILITY; HUMANS; INFECTION; INFLAMMATION; NEOPLASMS; SLEEP APNEA SYNDROMES;

EID: 84878373076     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2013.02.313     Document Type: Short Survey

References (35)

1. Fagot-Campagna A., Fosse S., Roudier C., et al. ENTRED. Caractéristiques, risque vasculaire et complications chez les personnes diabétiques. Evolution 2001-2007 en France métropolitaine. Bull Epidemiol Hebd 2009, (42-43):451-455.
2. Romon I., Jougla E., Weill A., et al. ENTRED. Description de la mortalité et des causes de décès dans une cohorte d'adultes diabétiques en France Métropolitaine. Bull Epidemiol Hebd 2009, (42-43):469-472.
3. Siegelaar S.E., Hickman M., Hoeskstra J.B.L., et al. The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis. Critical Care 2011, 15:R205.
4. Garcia C., Fève B., Ferré P., et al. Diabetes and inflammation: fundamental aspects and clinical implications. Diabetes Metab 2010, 36:327-338.
5. Avitabile N.A., Banka A., Fonseca V.A. Glucose control and cardiovascular outcomes in individual with diabetes mellitus. Lessons learned from the megatrials. Heart Fail Clin 2012, 8:513-522.
6. Homan R.R., Paul S.K., Bethel M.A., et al. 10 years follow up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359:1577-1589.
7. Gaede P., Lund-Andersen H., Parving H.H., Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591.
8. ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 2010, 31:2055-2501.
9. The BARI2D. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009, 360:2503-2515.
10. Nichols G.A., Hillier T.A., Erbey J.R., et al. Congestive heart failure in type 2 diabetes: prevalence, incidence and risk factors. Diabetes Care 2001, 24:1614-1619.
11. Boudina S., Abel E.D. Diabetic cardiomyopathy revisited. Circulation 2007, 115:3213-3223.
12. Johnson R.C., Leopold J.A., Loscalto J. Vascular calcifications: pathobiological mechanisms and clinical implications. Circ Res 2006, 99:1044-1059.
13. Megherbi S.E., Milan C., Munier D., et al. Association between diabetes and stroke sub-type on survival and functionnal outcome 3 months after stroke: data from the European BIOMED stroke project. Stroke 2003, 34:688-694.
14. Wong T.Y., Simô R., Mitchell P. Fenofibrate - a potential systemic treatment for diabetic retinopathy?. Am J Ophtalmol 2012, 154:6-12.
15. Kremer C.K., Rodrigues T.C., Canani L.H., et al. Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and type 2 diabetes. Diabetes Care 2011, 34:1238-1244.
16. Couchoud C., Villar E., Frimat L., et al. L'insuffisance rénale chronique terminale associée à un diabète: fréquence et conditions d'initiation du traitement de suppléance, France 2006. Bull Epidemiol Hebd 2008, 43:414-418.
17. Detournay B., Simon D., Guillausseau P.J., et al. Chronic kidney disease in type 2 diabetes patients in France. Prevalence, influence og glycaemic control and implication for the pharmacological management of diabetes. Diabetes Metab 2012, 38:102-112.
18. Adler A.I., Stevens R.J., Manley S.E., et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003, 63:225-232.
19. Gaede P., Tarnow L., Vedel P., et al. Remission to normoalbuminuria during mulrifactorial treatments preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial transplant 2004, 19:2784-2788.
20. Marre M., Sauvanet J.P. Réduire l'albuminurie : est-ce un facteur indépendant de diminution du risque cardio-vasculaire ?. Med Mal Metabol 2010, 4:441-447.
21. Hartemann A., Attal N., Bouhassira D. Prise en charge de la polyneuropathie diabétique douloureuse. Med Mal Metabol 2011, 5:208-222.
22. Mendell J.R., Sahenk Z. Clinical practice. Painful sensory neuropathy. N Engl J Med 2003, 348:1243-1255.
23. Boulton A.J.M., Vielekyte L., Ragnardon-Tennall G., Apelqvist J. The global burden of diabetic foot disease. Lancet 2005, 366:1719-1724.
24. Malgrange D. Physiopathologie du pied diabétique. Rev Med Int 2008, 29(Suppl 2):231-237.
25. Schuetz P., Castro P., Shapiro N.I. Diabetes and sepsis; preclinical findings and clinical relevance. Diabetes Care 2011, 34:771-778.
26. Kibatchi A.E., Umpierrez G.E., Miles J.M., Fisher J.N. Hyperglycemic crises in adult patients with diabetes. Diabetes care 2009, 32:1335-1343.
27. Lamport D.J., Lawton C.L., Mansfield M.W., Dye L. Impairment in glucose tolerance can have a negative impact on cognitive function: a systematic research review. Neurosci Biobehav Rev 2009, 33:394-413.
28. Roy T., Lloyd C.E. Epidemiology of depression in diabetes: a systematic review. J Affect Disorders 2012, 142(S1):S8-S21.
29. Moseley K.F. Type 2 diabetes and bone fractures. Curr Opin Endocrinol Diabetes Obes 2012, 19:128-135.
30. Janghorbani M., Van Dam R.M., Willett W.C., Hu F.B. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007, 166:495-505.
31. Kessler I.I. Cancer and diabetes mellitus. A review of the literature. J Chronic Dis 1971, 23:579-600.
32. Stattin P., Björ O., Ferrari P., et al. Prospective study of hyperglycemia and cancer risk. Diabetes Care 2007, 30:561-567.
33. Khaw K.T., Wareham N., Bingham S., et al. Glycated haemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European Prospective Investigation into Cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev 2004, 13:915-919.
34. Khader Y.S., Davod A.S., El-Qaderi S.S., et al. Periodontal status of diabetics compared with non diabetics: a meta-analysis. J Diabetes Complic 2006, 20:59-68.
35. Saremi A., Nelson A.G., Tulloch-Reid M., et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care 2005, 28:27-32.